VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ORMP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ORMPOramed Pharmaceuticals Inc.
$4.30$176M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksORMPPrice History

ORMP logoOramed Pharmaceuticals Inc. (ORMP) Stock Price History

Historical prices from 2006 to 2026

$4.30-0.27  (-5.91%)close Jul 7
Returns
1M
+18.1%
3M
+22.2%
YTD
+47.8%
1Y
+99.1%
3Y
+7.4%
5Y
-18.7%
ATH$31.73Jan 2014-86.4%
ATL$1.67Nov 2023pre-split
Avg Vol (50D)241K/ day
52-Week Range$1.98 — $5.19
LowCurrent: $4.30High

Loading 10-year price history...

ORMP Historical Performance

1 YearTotal Return
+110.6%
Price: +99.1%Div: +11.6%
3 YearsTotal Return
+31.1%
CAGR: +9.5%
Price: +23.9%
5 YearsTotal Return
-62.5%
CAGR: -17.8%
Price: -64.6%
YTD
+47.8%

ORMP Annual Returns

Year-by-year price performance · 2006–2026

Best+278.2%2013
Worst-81.4%2023
Up years10/21
2006-16.0%
2007-72.6%
2008+25.8%
2009+12.5%
2010-25.0%
2011-17.6%
2012+22.2%
2013+278.2%
2014-74.9%
2015+71.0%
2016-27.9%
2017+41.1%
2018-67.2%
2019+53.3%
2020-14.2%
2021+228.3%
2022-13.4%
2023-81.4%
2024-1.2%
2025+18.3%
2026+17.4%
2006 annual price return
-16.0%
2007 annual price return
-72.6%
2008 annual price return
+25.8%
2009 annual price return
+12.5%
2010 annual price return
-25.0%
2011 annual price return
-17.6%
2012 annual price return
+22.2%
2013 annual price return
+278.2%
2014 annual price return
-74.9%
2015 annual price return
+71.0%
2016 annual price return
-27.9%
2017 annual price return
+41.1%
2018 annual price return
-67.2%
2019 annual price return
+53.3%
2020 annual price return
-14.2%
2021 annual price return
+228.3%
2022 annual price return
-13.4%
2023 annual price return
-81.4%
2024 annual price return
-1.2%
2025 annual price return
+18.3%
2026 annual price return
+17.4%
LessMore
Alpha vs S&P 500
1Y+88.8%
3Y-8.5%
5Y-32.2%

Price returns only.

Download Historical Data

5,084 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

ORMP Stock Price Trajectory (2006–2026)

As of July 8, 2026, Oramed Pharmaceuticals Inc. (ORMP) trades at $4.30, representing a +99.1% return over the past year. The stock has delivered a -62.5% total return over five years (-18.7% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $31.73 on January 13, 2014. From this peak, ORMP has corrected -86.4%, currently trading 30% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers MNKD (+19.2% 1Y), NRXP (+23.4% 1Y), and PRAX (+594.0% 1Y), ORMP has underperformed the peer group average. Compare ORMP vs MNKD →

ORMP Historical Price Data · from 2006

Rows 1–50 of 5,084
Date Open High Low Close Volume Change %
2026-07-074.594.654.304.30234K-5.91%
2026-07-064.574.724.524.57281K-0.65%
2026-07-024.784.834.484.60361K-0.22%
2026-07-014.754.754.254.611.02M-4.16%
2026-06-304.634.864.604.81369K+3.66%
2026-06-294.494.704.384.64369K-0.64%
2026-06-264.995.114.524.670-6.60%
2026-06-254.325.194.305.001.18M+16.28%
2026-06-244.174.344.084.30203K+3.12%
2026-06-234.154.203.964.17365K+3.99%
2026-06-223.874.083.834.01190K+3.35%
2026-06-183.863.893.813.88149K+2.37%
2026-06-173.813.923.773.79238K+0.53%
2026-06-163.823.913.763.77122K-1.82%
2026-06-153.873.923.823.84136K-0.78%
2026-06-123.833.933.813.87113K+1.84%
2026-06-113.743.863.703.80158K+2.70%
2026-06-103.533.773.533.70174K+1.37%
2026-06-093.663.753.583.65217K+0.27%
2026-06-083.683.783.643.64132K-1.89%
2026-06-053.813.813.653.71100K-2.62%
2026-06-043.683.873.653.81164K+4.38%
2026-06-033.603.773.603.65363K+1.39%
2026-06-023.853.963.593.60386K-7.46%
2026-06-013.984.023.813.89176K-2.02%
2026-05-293.964.053.903.97121K+0.25%
2026-05-283.984.053.813.96326K-0.50%
2026-05-273.944.143.943.98134K-1.49%
2026-05-264.004.143.884.04311K+1.25%
2026-05-224.404.403.983.990-8.90%
2026-05-214.294.434.134.3881K+2.34%
2026-05-204.254.354.184.28149K-1.15%
2026-05-194.264.424.064.33285K+0.93%
2026-05-184.674.694.234.29380K-7.54%
2026-05-154.614.754.534.64174K-1.90%
2026-05-144.664.754.484.73118K+3.73%
2026-05-134.454.634.454.56184K+2.47%
2026-05-124.504.594.354.45156K-3.68%
2026-05-114.245.014.234.62604K+12.96%
2026-05-083.944.103.914.09258K+4.60%
2026-05-073.933.933.833.91103K-0.26%
2026-05-063.933.963.843.92136K-1.51%
2026-05-054.004.003.893.98137K+1.27%
2026-05-044.014.023.913.93100K-1.26%
2026-05-013.904.003.873.98108K+2.58%
2026-04-303.863.923.853.88113K+1.04%
2026-04-293.994.033.833.84166K-4.71%
2026-04-284.074.223.994.03228K-1.95%
2026-04-273.854.203.844.11425K+6.75%
2026-04-243.843.893.773.8560K+0.26%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ORMP — Frequently Asked Questions

Quick answers to the most common questions about buying ORMP stock.

How has ORMP stock performed recently?

ORMP returned +99.1% over the past year, beating its 5-year annualized CAGR of -18.7%. The stock trades above its 200-day moving average, confirming the uptrend.

What is ORMP's all-time high price?

Oramed Pharmaceuticals Inc. reached $31.73 on 2014-01-13. The 52-week high is $5.19. Current 1-year return of +99.1% places the stock closer to historical peaks.

Where can I download ORMP historical price data?

This page provides ORMP daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2006-2026, downloadable in CSV format.

464 data points · sampled from 5,084